chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Sweating; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.  Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the reported events, a causal relationship cannot be excluded.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up received: Outcome is updated to recovered/resolved.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the reported events, a causal relationship cannot be excluded.
Our son was developing normaly untill his vacinations at 18 months. He is now Autistic due to the MMR and the insult to his system He also came down with the measles which were diagnosed over the phone by MAPA. 02/21/2007 MR received from PCP.  12 and 18 month well baby checks show good growth and development.  Vax received at 18 month check(2/14/2006). Had febrile seizure since last visit (around 18 months-2/22/06) with possible regression since that time. On Trileptal. Next visit for 2 yr check with mention of speech regression.  DX with Autism in 11/06.  Care severed with PCP.    02/26/2007 MR received from ER visit of 02/22/2006 for c/o fever and not acting himself.  Parent reported one episode of vomiting the night prior. PE reveals Temp of 103'F.  Throat is red without purulence or edema.  Lung sounds-few scattered rhonchi.  Prolonged respiratory time.  Heartrate is rapid but RRR.  Otherwise WNL.   Impression:  Fever.  Probable febrile seizure.  04/02/2007 MR received from Pediatric Neurologist with several visits from 9/2006 to 3/2007 which decribe a speech delay which became evident following a febrile seizure in Feb. 2006.   PEs:  Speech delay noted-no formed words.  No eye contact or interaction with his environment.  Impressions:  10/23/2006:  Static encephalopathy with marked speech delay following febrile seizure.  12/06/2006:Static encephalopathy with expressive language delay in a clinical setting of normal head scan, EEG, and metabolic work-up.  Follow-up: My son is now disabled. The vaccines that we thought were keeping him healthy in fact were poisoning him. He is now Autistic. Follow-up: I have included patients vaccination record w/ any and all vaccinations w/ Mercury lead to his poisoning lot #s. He has Mercury poisoning! I hope that vaccines will be free of Mercury one day.
Client was vaccinated on 02/08/2021.Client stated that she felt pain ,tingling, and numbness at the injection site and felt like it crawled up to her left side of face and and head behind her left ear. The numbness  and tingling was also down her left arm. No facial droop was noted. Client denied visual change. Client was placed on oxygen and 911 was called for assistance. Client was seen at ER department. She was evaluated, had blood work done and released with Dx of headache due to paresthesia.
10/13/05 11:55am c/o "feeling weird" and "thinking everything is funny" and of "being able to hear heart beat in my ears".  BP=126/76, P=80, strong and regular. respiration regular and non labored. "loud " heartbeat kept her awake 10/13/05 pm called private MD office 10/14/05 and was advised by nurse on call MD to seek emergency care if in acute distress. Did not seek emergency care was evaluated by pt  on 10/17/05. Ability to "hear heart beat continued until 10/19/05, C/O "numbness in mouth on 10/18/05 and 10/20/05 - resolved 10/21/05.
This spontaneous case was reported by a consumer and describes the occurrence of RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue). At the time of the report, RECTAL DISCHARGE (episodes of very very light brown fluid rectal discharges), DIARRHOEA (diarrhea) and FATIGUE (episodes of fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Patient received first shot of shingle on December 2020. No Relevant concomitant medications was reported. Treatment information included patient took low dense food and electrolyte for the episodes of rectal discharges.   This case was linked to US-MODERNATX, INC.-MOD-2021-039318 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-039318:1st dose
4 days after shot: shortness of breath, numbness, chest pain. Feeling  hot but no fever. still continuing as of 9/29/2021
pt reported w/in 1wk of vax exp tiredness, sore chest;seen by MD;10NOV97 exp severe pain in feet & achilles tendons & numbness & cramping of feet;referred to neuro 9JAN98 d/t persistent pain;dx autoimmune rxn to vax; 60 day follow up states the neuropathy remains the same.
On 10/9/04, my son took DTaP and Prevnar on 11/21/04. He was sitting in the kitchen floor playing; he started making a choking sound. I called the doctor and took him to the doctor and they put him in the hospital. He liked to have died. They had the crash cart because he couldn't breathe.
Information has been received from a health professional concerning a 22 month old male, with no medical history and no allergies, who on 04/23/2004 was vaccinated with a dose of varicella virus vaccine live.  It was reported that on 03/12/2005 the patient experienced chickenpox breakthrough on his back and legs.  It was noted that the patient's improvement and present status were unknown.  There were no laboratory or diagnostic tests performed.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  The patient's sister experienced chickenpox breakthrough on the back of her legs following vaccination with varicella virus vaccine live (oka/merck).  Additional information has been requested. This is in follow-up to report (s) previouly submitted on 5/16/2005. Information has been received from a health professional concerning a 22 month male, with no medical history and no allergies, who on 23-APR-2004 was vaccinated with a first dose of VARIVAX (Merck) (Lot# 641987/1018N). It was noted that there was no illness at the time of vaccination. It was reported that on 12-MAR-2005, at 10:00 am, the patient experienced chickenpox breakthrough on his back and legs. It was noted that the patient's improvement and present status were unknown. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a health professional indicated that the patient experienced a varicella rash with approximately 20 erythematous, maculopapular lesions on his trunk and extremities with some crusting and scabbing. Subsequently on 17-MAR-2005 the patient recovered. The patient's sister experienced chickenpox breakthrough on the back of her legs following vaccination with VARIVAX (Merck) (WAES# 0503USA02495). Additional information is not expected.
Need was not all the way on the syringe and most of the vaccine did not make it into the patient
rash is still getting worse,Rash is still spreading all over her; itches on face; bumps (rash), increased spreading all over; felt itching started from thighs (above knees); itches were horribly over a week especially bends of the arms (elbows); second dose was on the day 25th (before day 26); soreness; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was on the day 25th (before day 26)), PRURITUS (felt itching started from thighs (above knees)), PRURITUS (itches were horribly over a week especially bends of the arms (elbows)), PRURITUS (itches on face) and RASH (bumps (rash), increased spreading all over) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was on the day 25th (before day 26)), MYALGIA (soreness) and FATIGUE (Tired). On 12-Apr-2021, the patient experienced PRURITUS (felt itching started from thighs (above knees)), PRURITUS (itches were horribly over a week especially bends of the arms (elbows)) and RASH (bumps (rash), increased spreading all over). On 22-Apr-2021, the patient experienced PRURITUS (itches on face). On 28-Apr-2021, the patient experienced RASH (rash is still getting worse,Rash is still spreading all over her). The patient was treated with METHYLPREDNISOLONE at a dose of 4 mg and TRIAMCINOLONE ACETONIDE at a dose of .25 gram twice a day. On 29-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was on the day 25th (before day 26)) had resolved. At the time of the report, PRURITUS (felt itching started from thighs (above knees)), PRURITUS (itches were horribly over a week especially bends of the arms (elbows)), PRURITUS (itches on face), RASH (bumps (rash), increased spreading all over), MYALGIA (soreness), FATIGUE (Tired) and RASH (rash is still getting worse,Rash is still spreading all over her) outcome was unknown.            This case was linked to MOD-2021-085763 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: follow up received on 28-apr-2021 has new Events were updated 1)Given steroid treatments and steroid shots2) rash is still getting worse3)Rash is still spreading all over her
Patient complained of sore arm for 2 weeks. Then reported severe pain and unable to move her arm (L). Going to MD on 2/1/16.
My left arm was initially sore. Over the course of weeks since the injection the soreness has continued and worsened in the deltoid muscle area, affecting mobility in that arm and interfering with sleeping on my left side.
Information has been received from a licensed practical nurse concerning a 15 year old female patient who on 17-DEC-2007, was vaccinated IM with a 0.5ml dose of Gardasil. On 24-JAN-2008, the patient experienced symptoms of nausea, abdominal pain and a little bit of weight loss. Unspecified medical attention was sought. At the time of this report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested. 10/08/08 This is in follow-up to report(s) previously submitted on 3/14/2008. Information has been received from a licensed practical nurse and an other health professional concerning a 15 year old female patient who on 17-DEC-2007, was vaccinated IM with a 0.5ml dose of GARDASIL. On 24-JAN-2008, the patient experienced symptoms of nausea, abdominal pain and a little bit of weight loss. Unspecified medical attention was sought. At the time of this report, the patient had not recovered. On 18-FEB-2008, the patient was vaccinated IM into the left arm with a second dose of GARDASIL (Lot # 659962/1740U). It was reported that the patient had lost weight for 5 months. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
On 11-26-05 arm broke out in a red, raised, itchy rash.  Arm sore.  On 11-28 rash down to elbow.  On 11-29 a few raised areas to his wrist.  Instructed to take Benadryl.  IF worsens, see MD.
Patient received Pfizer COVID vaccine on 3/16/21 and 4/6/21. Patient tested COVID positive on 8/24/21, came to our ED, received a dose of remdesivir, was not requiring oxygen, and was discharged home. On 8/31/21, patient came back to the hospital and found to be hypoxic on room air with bilateral infiltrates on chest x-ray. He was admitted from 8/31/21 to 9/4/21 for COVID-19 pneumonia and received dexamethasone during admit.
Fever over 105 degrees, extreme shaking, hands and feet freezing for hours, hyper sensitive skin with pain everywhere. Took ibuprofen and acetaminophen to help with fever. It did very little to help with it. 24 hours later, and I'm feeling better, although still feel like crud.
Patient experienced large swelling in her left arm and the injection site became very painful 4-5 hours after receiving her 2nd dose of SHINGRIX. Her entire body was itching and it came very uncomfortable.  Patient thought it was a normal adverse reaction and try to put up with it but later that night it became worse and she decided to go to emergency room (ER). ER gave her high steroids dose (Prednisone) and BENADRYL. She stopped back the next morning to drop off prescription for BENADRYL 50 mg taper instructions for Prednisone 20 mg.
I started by having an occasional burning and tingling sensation in both feet while sleeping and the tingling sensation has moved up my  legs.  Now about mid calf.  The tingling sensation does not go away and there are still occasional  burning flashes -- mostly at night.  Hard to know when it started but called the Dr in July.  I have injured my back in the past and have two replaced hips -- replaced 8-10 yrs ago so initially thought it might be a pinched nerve or disk-- but no disc /back pain
This spontaneous report was received from a Medical Assistant referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with an improperly stored dose of PROQUAD (Merck) lot # L002418 with expiration date of 23-JUL-2016 (anatomical route of vaccination and dose number were not provided). The Medical Assistant started that PROQUAD (Merck) was exposed to a temperature excursion of 37.2 degree F for 15 hours. Additionally, the vaccine was not involved on a previous temperature excursion. The call was made due to a data logger. Furthermore, no adverse events were reported and no product quality issue was involved. Additional information has been requested.
Six hours after got a headache, nine hours later got a wild fever and aches - every joint in my body ached, fever went up to 102.2, uncontrollable shaking. Treated with Tylenol and hot showers. Overnight fever calmed down to 100-101 range, for three days hovered in 99 range.
I got the shots years ago and I now have shingles/Suspected Vaccination Failure; now have shingles; still hurts like heck; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I got the shots years ago and I now have shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: now have shingles) and pain (Verbatim: still hurts like heck). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 24-JUL-2023 This case was reported by a patient via interactive digital media. The patient got the shingles shots years ago and he/she now had shingles. The reporter stated that it might be and it was not full force but it still hurt like heck. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
(L) arm pain at injection site, began after injection and became more severe over time. Saw his primary care physician - no treatment provided. Pain is still present at time of this report, worsening, especially with touch.
Severe swollen right eye (closed shut), slightly swollen left eye, swollen right cheek, sneezing, runny nose, itchy eyes. Still having swelling symptoms. Using Benedryl and 20mls Prednisolone for next 3 days.
This literature report has been received from the authors of a published article. In this case series, the authors described seven immunized healthy children without a history of primary varicella who presented with herpes zoster that correlated with the vaccination site of live attenuated varicella-zoster vaccine. These cases highlight the varied clinical presentations and diagnostic and therapeutic considerations for herpes zoster in healthy children. Seven vaccinated healthy children without underlying immunodeficiency presented with herpes zoster in the limb that correlated with the vaccination site. Their clinical histories are summarized. Each patient underwent varicella zoster vaccination at 12 to 14 months of age. The pediatrician's office confirmed the site of vaccination in six patients and the parents in the seventh. Median age at presentation was 3 years (range 1.5-6 years). There were no precipitating factors elicited by history in five patients; one patient developed the rash at the site of recent influenza vaccination and one patient developed the rash after surgery. The morphology of the lesions included erythematous papules, pseudovesicles, pustules, and plaques, with associated pain in two patients and pruritus in three. Systemic symptoms ranged from none to low-grade fevers, upper respiratory symptoms, and joint pain. Clinical and laboratory findings, specifically positive direct fluorescent antibody (DFA) testing, were consistent with herpes zoster in four cases; because of distinct similarities in the clinical examination, DFA testing was not conducted in the other three cases. Acyclovir was prescribed for five patients but deferred in two because of the mild or late presentation. The evaluating physician's differential diagnosis in the seven cases included viral exanthem, eczema herpeticum, atopic dermatitis, contact dermatitis, microcystic lymphatic malformation, herpes simplex infection, and herpes zoster infection. In one patient with knee pain, there was initial concern for septic hip, but inflammatory markers were not elevated, joint effusion was not seen on ultrasound, and the rash and knee pain self-resolved after several days. This report refers to a 3 year old male patient without a history of primary varicella. On an unknown date, the patient was vaccinated with varicella-zoster vaccine (code as "varicella virus vaccine live (Oka/Merck) (manufacturer unknown), Zoster Vaccine Live (manufacturer unknown) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (manufacturer unknown)") (dose and route unknown, left leg) for prophylaxis. On an unknown date (reported as 28 months later), the patient experienced herpes zoster in left leg (in L1-L2 dermatomal distribution) with symptoms of painful lesions. The patient did not have direct fluorescent antibody (DFA) test. The patient received acyclovir treatment for the event for 10 days. The outcome of the event was recovered without complications. The reporter considered the event of herpes zoster was related to the suspected therapies. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1802USA003640.
About 2 months after the 2nd dose vaccine, I started getting shortness of breath and tightness in my chest. Around end of May, the pressure started getting heavier. By June 5, 2021 I thought I was having a possible heart attack, so I decided to go to the Hospital. They did a bunch of tests and an ECHO and detected pericarditis, pericardio effusion and blood clots. I was on a heparin drip for 7 days for the blood clot and they started me on colchicine for the pericarditis which has now resolved. I was discharged with RX for Lovenox to prevent blood clots and to continue to take colchicine. I was in the hospital for 8 days total.
Patient states after receiving vaccine she experienced a large circular welt at the injection site.  She was advised by MD to not received second dose of vaccine.
This spontaneous report was received from a nurse, referring to a patient of unknown age. and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 28-JAN-2019, the patient was vaccinated with PROQUAD 0.5 ml, once, lot# R015744, expiration date 12-FEB-2019, subcutaneously, for prophylaxis (strength was not reported) reconstituted with an expired dose of sterile diluent subcutaneously, lot # N008378 and 08-JUN-2018 (strength, dose, frequency and indication were not reported). No adverse effects were reported.
Approx 5 min after receiving immz, pt appeared to have a seizure; loss of consciousness <45 seconds, jerky movements, urinated on self.  Ammonia inhalant used, pt. conscious, pale color, O2 givenapprox after 1 minute pt AOX3.  However, approx in the next 3 minutes pt again appears to have another seizure in the same manner as above, lasting approx <45 seconds.  911 called, pt stabilized and transported to ER.  I spoke with the parent the next day and she advises that they discharged her and diagnosed her as having a seizure and the follow up; the parent advised she will follow up.  6/10/09 Received ER medical records of 6/1/2009. FINAL DX: acute syncopal episode, mild volume depletion Records reveal patient experienced altered mental status x 2 episodes, dizziness, hypotonia & orthostatic collapse w/fall, tonic-clonic seizure-like activity, urinary incontinence.  Was hypotensive in ER.  Tx w/IVF, improved & d/c to home w/PCP f/u.  Returned to ER on 6/2/09.  FINAL DX: Fever, viral syndrome. Experienced low-grade fever.  Tx w/IV antibiotic.  LP performed.
developmental regression.  Stopped using pronouns, which he had been using for months.  As of today, he still does not use them.